70839-362 : Cocaine Hydrochloride 40 mg/ml Nasal Solution


NDC: 70839-362
Labeler: Lxo Us Inc.
Product Type: Human Prescription Drug
Drug Name:  Cocaine Hydrochloride
Dosage Form: Nasal Solution
Application #: NDA209963
Rev. Date: 
CSA Schedule: CII (US) [1]


[1] Schedule II / IIN Controlled Substance: High potential for abuse which may lead to severe psychological or physical dependence. (i.e. Narcotics such as Dilaudid, Methadone, Demerol, Oxycodone, Percocet, Fentanyl, Morphine, Opium, Codeine, and Hydrocodone ... Schedule IIN stimulants include non-narcotic Amphetamines such as Dexedrine, Adderall, Desoxyn, Methylphenidate (Ritalin) ... Other Schedule II substances include Amobarbital, Glutethimide, and Pentobarbital. More Details: US Dept of Justice Controlled Substance Schedules.

NDC Package Codes:

  • 70839-362-04: 1 BOTTLE, GLASS IN 1 CARTON (70839‑362‑04) / 4 ML IN 1 BOTTLE, GLASS

Active Ingredients:

  • Cocaine Hydrochloride

Dosage Strength:

  • 40 mg/mL

Related Products:

Based on records with the same trade name.
  • 0527-1728 Cocaine Hydrochloride 40 mg/ml Topical Solution by Lannett Company, Inc.
  • 0527-1729 Cocaine Hydrochloride 100 mg/ml Topical Solution by Lannett Company, Inc.
  • 64950-362 Cocaine Hydrochloride 40 mg/ml Nasal Solution by Genus Lifesciences Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 70839-362 QR Code

< Prev: 70839-325Next: 70840-001 >

Related Discussions:

Can methotrexate cause a false positive for Cocaine?
I give myself weekly injections of 1cc of methotrexate. I got a false positive for cocaine. I have never used cocaine. C... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.